RT Journal Article
SR Electronic
T1 Risk of Thromboembolic Events Following COVID-19 Diagnosis Without Hospitalization
JF The Journal of the American Board of Family
                Medicine
JO J Am Board Fam Med
FD American Board of Family Medicine
SP 1163
OP 1167
DO 10.3122/jabfm.2022.220180R2
VO 35
IS 6
A1 Katherine Schreck
A1 Caroline Carlin
A1 Jason Ricco
YR 2022
UL http://www.jabfm.org/content/35/6/1163.abstract
AB Introduction: Current research shows no increased risk of thromboembolic events with mild COVID-19 but does not account for comorbidities. The aim of this study was to examine the incidence of thromboembolic events, including pulmonary embolism, cerebral infarction, and deep vein thrombosis, in nonhospitalized patients diagnosed with COVID-19 while accounting for comorbidities such as diabetes, asthma, COPD and cancer.Methods: We completed a large retrospective observational analysis of adult patients within a large urban health system.Results: Using a logit framework (with and without propensity score weighting), there was no increased risk of thromboembolic events among patients positive for SARS-CoV-2 who did not require hospitalization for COVID-19.Conclusion: This data suggest prophylactic anticoagulation is likely not warranted in the outpatient setting.